S 344 Hatch Waxman Integrity Act of 2019
US Congress 116th Congress
Hatch-Waxman Integrity Act of 2019
S.344
About S.344
A bill to amend the Federal Food, Drug, and Cosmetic Act and the Securities Exchange Act of 1934 to prevent the inter partes review process for challenging patents from diminishing competition in the pharmaceutical industry and with respect to drug innovation, and for other purposes.
Bill Texts
Introduced 02/21/2019
Weigh In
No votes yet!
Cast yours now to be the first.
Votes for: 0 Votes against: 0
Spread the Word!
Gettr
Sponsors (1)
